Shree Ganesh Biotech India Q3FY22 net profit climbs to Rs. 95.01 lakhs

Shree Ganesh Biotech (India) Ltd has reported Standalone financial results for the period ended December 31, 2021.

Financial Results (Q3 FY2022) - QoQ Comparison

The company has reported total income of Rs. 19.0313 crores during the period ended December 31, 2021 as compared to Rs. 17.9618 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs. 0.9501 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 0.8241 crores for the period ended September 30, 2021.

The company has reported EPS of Rs. 0.48 for the period ended December 31, 2021 as compared to Rs. 0.41 for the period ended September 30, 2021.

Financials	Q3 FY2022	Q2 FY2022	% Change
Total Income	₹ 19.0313 crs	₹17.9618 crs	5.95%
Net Profit	₹0.9501 crs	₹0.8241 crs	15.29%
EPS	₹0.48	₹0.41	17.07%

Financial Results (Q3 FY2022) - YoY Comparison

The company has reported total income of Rs. 19.0313 crores during the period ended December 31, 2021 as compared to Rs.7.8423 crores during the period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.0.9501 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.0.3661 crores for the period ended December 31, 2020.

The company has reported EPS of Rs.0.48 for the period ended December 31, 2021 as compared to Rs.0.18 for the period ended December 31, 2020.

Financials	Q3 FY2022	Q3 FY2021	% Change
Total Income	₹ 19.0313 crs	₹7.8423 crs	142.67%
Net Profit	₹0.9501 crs	₹0.3661 crs	159.52%
EPS	₹0.48	₹0.18	166.67%

Financial Results (9 Months Ended FY2022) - YoY Comparison

The company has reported total income of Rs.52.5556 crores during the 9 Months period ended December 31, 2021 as compared to Rs.7.9558 crores during the 9 Months period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.2.4564 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.0.2866 crores for the 9 Months period ended December 31, 2020.

The company has reported EPS of Rs.1.23 for the 9 Months period ended December 31, 2021 as compared to Rs.0.14 for the 9 Months period ended December 31, 2020.

Financials	9 Months Ended FY2022	9 Months Ended FY2021	% Change
Total Income	₹52.5556 crs	₹7.9558 crs	560.59%
Net Profit	₹2.4564 crs	₹0.2866 crs	757.08%
EPS	₹1.23	₹0.14	778.57%

Shares of Shree Ganesh Biotech (India) Ltd was last trading in BSE at Rs. 129.25 as compared to the previous close of Rs. 123.85. The total number of shares traded during the day was 52823 in over 835 trades.

The stock hit an intraday high of Rs. 131.50 and intraday low of 125.25. The net turnover during the day was Rs. 6717822.00.

Source : Equity Bulls

Keywords

ShreeGaneshBiotechIndia Q3FY22 9MFY22 ResultUpdate